Literature DB >> 31945301

Altered Lipid Domains Facilitate Enhanced Pulmonary Vasoconstriction after Chronic Hypoxia.

Charles E Norton1, Laura Weise-Cross1, Rosstin Ahmadian1, Simin Yan1, Nikki L Jernigan1, Michael L Paffett1, Jay S Naik1, Benjimen R Walker1, Thomas C Resta1.   

Abstract

Chronic hypoxia (CH) augments depolarization-induced pulmonary vasoconstriction through superoxide-dependent, Rho kinase-mediated Ca2+ sensitization. Nicotinamide adenine dinucleotide phosphate oxidase and EGFR (epidermal growth factor receptor) signaling contributes to this response. Caveolin-1 regulates the activity of a variety of proteins, including EGFR and nicotinamide adenine dinucleotide phosphate oxidase, and membrane cholesterol is an important regulator of caveolin-1 protein interactions. We hypothesized that derangement of these membrane lipid domain components augments depolarization-induced Ca2+ sensitization and resultant vasoconstriction after CH. Although exposure of rats to CH (4 wk, ∼380 mm Hg) did not alter caveolin-1 expression in intrapulmonary arteries or the incidence of caveolae in arterial smooth muscle, CH markedly reduced smooth muscle membrane cholesterol content as assessed by filipin fluorescence. Effects of CH on vasoreactivity and superoxide generation were examined using pressurized, Ca2+-permeabilized, endothelium-disrupted pulmonary arteries (∼150 μm inner diameter) from CH and control rats. Depolarizing concentrations of KCl evoked greater constriction in arteries from CH rats than in those obtained from control rats, and increased superoxide production as assessed by dihydroethidium fluorescence only in arteries from CH rats. Both cholesterol supplementation and the caveolin-1 scaffolding domain peptide antennapedia-Cav prevented these effects of CH, with each treatment restoring membrane cholesterol in CH arteries to control levels. Enhanced EGF-dependent vasoconstriction after CH similarly required reduced membrane cholesterol. However, these responses to CH were not associated with changes in EGFR expression or activity, suggesting that cholesterol regulates this signaling pathway downstream of EGFR. We conclude that alterations in membrane lipid domain signaling resulting from reduced cholesterol content facilitate enhanced depolarization- and EGF-induced pulmonary vasoconstriction after CH.

Entities:  

Keywords:  caveolae; caveolin-1; membrane cholesterol; pulmonary hypertension

Mesh:

Substances:

Year:  2020        PMID: 31945301      PMCID: PMC7258824          DOI: 10.1165/rcmb.2018-0318OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  61 in total

1.  Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway.

Authors:  C Tiruppathi; W Song; M Bergenfeldt; P Sass; A B Malik
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

2.  Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis.

Authors:  S Li; K S Song; S S Koh; A Kikuchi; M P Lisanti
Journal:  J Biol Chem       Date:  1996-11-08       Impact factor: 5.157

3.  Mechanical strain-induced RhoA activation requires NADPH oxidase-mediated ROS generation in caveolae.

Authors:  Ying Zhang; Fangfang Peng; Bo Gao; Alistair J Ingram; Joan C Krepinsky
Journal:  Antioxid Redox Signal       Date:  2010-10-01       Impact factor: 8.401

4.  Pressure-induced smooth muscle cell depolarization in pulmonary arteries from control and chronically hypoxic rats does not cause myogenic vasoconstriction.

Authors:  Jay S Naik; Scott Earley; Thomas C Resta; Benjimen R Walker
Journal:  J Appl Physiol (1985)       Date:  2004-10-22

5.  Presence of oxidized cholesterol in caveolae uncouples active platelet-derived growth factor receptors from tyrosine kinase substrates.

Authors:  P Liu; P Wang; P Michaely; M Zhu; R G Anderson
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

6.  A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane.

Authors:  E J Smart; Y s Ying; W C Donzell; R G Anderson
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

7.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

8.  Inhibition of GTP-dependent vesicle trafficking impairs internalization of plasmalemmal eNOS and cellular nitric oxide production.

Authors:  Suvro Chatterjee; Sheng Cao; Timothy E Peterson; Robert D Simari; Vijay Shah
Journal:  J Cell Sci       Date:  2003-07-22       Impact factor: 5.285

9.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.

Authors:  M P Lisanti; P E Scherer; J Vidugiriene; Z Tang; A Hermanowski-Vosatka; Y H Tu; R F Cook; M Sargiacomo
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Caveolin-1 Expression and Hemodynamics in COPD Patients.

Authors:  Lars C Huber; Alex Soltermann; Manuel Fischler; Steffen Gay; Walter Weder; Erich W Russi; Rudolf Speich; Silvia Ulrich
Journal:  Open Respir Med J       Date:  2009-05-13
View more
  2 in total

1.  Membrane depolarization is required for pressure-dependent pulmonary arterial tone but not enhanced vasoconstriction to endothelin-1 following chronic hypoxia.

Authors:  Charles E Norton; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Pulm Circ       Date:  2020-12-08       Impact factor: 3.017

2.  Cholesterol: A Novel Regulator of Vasoreactivity in Pulmonary Arteries.

Authors:  Benjamin Grimmer; Wolfgang M Kuebler
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.